Long Noncoding RNA LINC00958 Accelerates Gliomagenesis Through Regulating miR-203/CDK2

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in biological processes.
• The specific mechanisms of lncRNAs in gliomagenesis remain largely unclear.
• This study focuses on the function of LINC00958 in glioma tumorigenesis.

Purpose of the Study:

• To investigate the role of long intergenic noncoding RNA 00958 (LINC00958) in glioma.
• To elucidate the molecular mechanism by which LINC00958 influences glioma development.
• To determine the prognostic significance of LINC00958 in glioma patients.

Main Methods:

• Quantitative real-time PCR to measure LINC00958 expression in glioma tissues and cell lines.
• In vitro and in vivo loss-of-function experiments (siRNA knockdown) to assess LINC00958's impact on glioma cell behavior.
• Bioinformatics analysis and luciferase reporter assays to identify and validate interactions between LINC00958, miR-203, and CDK2.

Main Results:

• LINC00958 was significantly upregulated in glioma tissues and cell lines compared to normal controls.
• Overexpression of LINC00958 correlated with a poorer prognosis in glioma patients.
• Knockdown of LINC00958 inhibited glioma cell proliferation and invasion, induced G0/G1 cell cycle arrest, and suppressed tumor growth in vivo.
• LINC00958 directly interacts with miR-203, and miR-203 targets CDK2, suggesting a regulatory axis.

Conclusions:

• LINC00958 functions as an oncogenic lncRNA in gliomagenesis.
• The LINC00958/miR-203/CDK2 pathway plays a critical role in glioma development.
• LINC00958 represents a potential therapeutic target for glioma treatment.